Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-05-05 16:51:19 ET · period of report 2026-05-01 · accession 0000875320-26-000175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-05 16:51 | 2026-05-01 | VRTX | Bhatia Sangeeta N. | Dir | A - Grant | $0.00 | +943 | 5,242 | +22% | $0 |
| T | 2026-05-05 16:51 | 2026-05-04 | VRTX | Bhatia Sangeeta N. | Dir | S - Sale | $423.73 | -318 | 4,924 | -6% | -$134.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 943 | $0.00 | 5,242 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Common | Common Stock | 2026-05-04 | S | D | 318 | $423.73 | 4,924 | D | — | — | (F2) Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/27/2025. |